ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.042,00
0,18%
S&P 500
6.049,24
0,88%
Dow Jones
44.025,81
1,24%
Euro vs US Dollar
1,04105
0,05%
Bitcoin
105.526,00
-0,61%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. NeoGenomics Inc (NEO) Börsenkurse

NeoGenomics Inc

NeoGenomics Inc (NEO)

Neo Energy Metals Plc
Neo Performance Materials Inc
14,18
-0,03
(-0,21%)
Geschlossen 22 Januar 10:00PM
Verzögert um 15 Minuten
14,18
-0,02
(-0,14%)
Nach Börsenschluss: 1:18AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
14,18
Gebot
14,18
Fragen
14,66
Volumen
1.196.719
14,06 Tagesbereich 14,77
12,125 52-Wochen-Bereich 19,115
Marktkapitalisierung
1,82B
Handelsende
14,21
Handelsbeginn
14,33
Letzte Trade
2
@
14.22
Letzter Handelszeitpunkt
Finanzvolumen
US$ 17.178.388
VWAP
14,3546
Durchschnittliches Volumen (3 Mio.)
869.295
Ausgegebene Aktien
128.360.871
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-20,72
Gewinn pro Aktie (EPS)
-0,69
Erlöse
591,64M
Nettogewinn
-87,97M

Über NeoGenomics Inc

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogen... NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services. Mehr anzeigen

Sektor
Testing Laboratories
Branche
Coml Physical, Biologcl Resh
Website
www.neogenomics.com
Hauptsitz
Carson City, Nevada, USA
Gegründet
2005
NeoGenomics Inc is listed in the Testing Laboratories sector of the NASDAQ with ticker NEO. The last closing price for NeoGenomics was US$14,21. Over the last year, NeoGenomics shares have traded in a share price range of US$ 12,125 to US$ 19,115.

NeoGenomics currently has 128.360.871 shares in issue. The market capitalisation of NeoGenomics is US$1,82 billion. NeoGenomics has a price to earnings ratio (PE ratio) of -20.72.

NEO Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities

16 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 Januar 2025
Edgar (US Regulatory)

Form 8-K - Current report

15 Januar 2025
Edgar (US Regulatory)

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

Long-Range Plan reflects 12-13% revenue growth annually Presentation and webcast at 43rd Annual J.P. Morgan Healthcare Conference today, Wednesday, January 15, at 1:30 p.m. PT / 4:30 p.m. ET...

15 Januar 2025
Business Wire

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

SEATTLE and FORT MYERS, Fla., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics...

14 Januar 2025
GlobeNewswire Inc.

Form 8-K - Current report

10 Januar 2025
Edgar (US Regulatory)

NeoGenomics Announces Chief Executive Officer Succession

Chris Smith to retire effective April 1, 2025; Board Member Tony Zook named incoming CEO Company reaffirms Fiscal 2024 financial guidance NeoGenomics, Inc. (“NeoGenomics” or the “Company”...

10 Januar 2025
Business Wire

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. Chris Smith, Chief...

06 Januar 2025
Business Wire
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
11.3710.694769711212.8116.1812.255178891014.17348395CS
4-2.39-14.423657211816.5719.11512.125116470414.89950904CS
120.775.7419835943313.4119.11512.12586929515.72416755CS
26-0.42-2.8767123287714.619.11512.12581693115.52173654CS
52-1.74-10.929648241215.9219.11512.12582299915.14375262CS
156-7.38-34.230055658621.5623.786116591513.49803921CS
260-17.86-55.742821473232.0461.576104457322.20345537CS

NEO - Frequently Asked Questions (FAQ)

What is the current NeoGenomics share price?
The current share price of NeoGenomics is US$ 14,18
How many NeoGenomics shares are in issue?
NeoGenomics has 128.360.871 shares in issue
What is the market cap of NeoGenomics?
The market capitalisation of NeoGenomics is USD 1,82B
What is the 1 year trading range for NeoGenomics share price?
NeoGenomics has traded in the range of US$ 12,125 to US$ 19,115 during the past year
What is the PE ratio of NeoGenomics?
The price to earnings ratio of NeoGenomics is -20,72
What is the cash to sales ratio of NeoGenomics?
The cash to sales ratio of NeoGenomics is 3,08
What is the reporting currency for NeoGenomics?
NeoGenomics reports financial results in USD
What is the latest annual turnover for NeoGenomics?
The latest annual turnover of NeoGenomics is USD 591,64M
What is the latest annual profit for NeoGenomics?
The latest annual profit of NeoGenomics is USD -87,97M
What is the registered address of NeoGenomics?
The registered address for NeoGenomics is 112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703
What is the NeoGenomics website address?
The website address for NeoGenomics is www.neogenomics.com
Which industry sector does NeoGenomics operate in?
NeoGenomics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
263,47M
DWTXDogwood Therapeutics Inc
US$ 3,18
(70,05%)
24,31M
USEGUS Energy Corp
US$ 3,74
(61,21%)
107,79M
DOGZDogness International Corporation
US$ 27,62
(52,60%)
1,95M
MYNAMynaric AG
US$ 0,6697
(50,83%)
3,72M
GOEVCanoo Inc
US$ 0,3748
(-72,24%)
41,38M
SHOTWSafety Shot Inc
US$ 0,1094
(-47,40%)
18,06k
ORKTOrangeKloud Technology Inc
US$ 0,7068
(-36,89%)
7,48M
HEPAHepion Pharmaceuticals Inc
US$ 0,3219
(-31,36%)
1,66M
WNWMeiwu Technology Company Ltd
US$ 0,2681
(-27,05%)
11,02M
GCTKGlucoTrack Inc
US$ 0,1226
(44,41%)
613,28M
CRKNCrown Electrokinetics Corporation
US$ 0,1121
(-10,32%)
392,52M
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
262,98M
RIMEAlgorhythm Holdings Inc
US$ 0,034599
(-16,83%)
230,08M
RGTIRigetti Computing Inc
US$ 13,97
(42,12%)
226,81M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
NEO
NeoGenomics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten